{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T02:37:59Z","timestamp":1775615879409,"version":"3.50.1"},"reference-count":9,"publisher":"Elsevier BV","issue":"26","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T00:00:00Z","timestamp":1653436800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.vaccine.2022.04.095","type":"journal-article","created":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T16:50:00Z","timestamp":1652115000000},"page":"3490-3494","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["WHO working group meeting to amend WHO Recommendations to assure the quality, safety and efficacy of live attenuated yellow fever vaccines"],"prefix":"10.1016","volume":"40","author":[{"given":"Javier","family":"Martin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan David Thomas","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dianliang","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Minor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.04.095_b0005","doi-asserted-by":"crossref","unstructured":"Gaythorpe KA, Hamlet A, Jean K, Garkauskas Ramos D, Cibrelus L, Garske T,Ferguson N. Elife. The global burden ofyellowfever. 2021 Mar 16;10:e64670. doi: 10.7554\/eLife.64670.PMID:33722340,","DOI":"10.7554\/eLife.64670"},{"key":"10.1016\/j.vaccine.2022.04.095_b0010","unstructured":"World Health Organization. Yellow fever vaccine, WHO position paper. Weekly Epidemiological Record, 2013, 88:269\u2013284. https:\/\/www.who.int\/wer\/2013\/wer8827.pdf?ua=1."},{"key":"10.1016\/j.vaccine.2022.04.095_b0015","unstructured":"WHO Recommendations to assure the quality safety and efficacy of live attenuated yellow fever vaccines. In: WHO Expert Committee on Biological Standardization: sixty-first report. Geneva: World Health Organization; 2013: Annex 5 (WHO Technical Report Series, No. 978). https:\/\/cdn.who.int\/media\/docs\/default-source\/biologicals\/vaccine-standardization\/yellow-fever\/trs_978_annex_5.pdf?sfvrsn=446b9c12_3&download=true ."},{"key":"10.1016\/j.vaccine.2022.04.095_b0020","unstructured":"Recommendations to assure the quality, safety and efficacy of poliomyelitis vaccines (oral, live, attenuated). In: WHO Expert Committee on Biological Standardization: sixty-third report. Geneva: World Health Organization; 2014: Annex 2 (WHO Technical Report Series, No. 980). https:\/\/cdn.who.int\/media\/docs\/default-source\/biologicals\/vaccine-standardization\/poliomyelitis\/opv_recommendations_trs_980_annex_2.pdf?sfvrsn=c2c7b612_3&download=true ."},{"key":"10.1016\/j.vaccine.2022.04.095_b0025","unstructured":"Revision of the WHO Recommendations to assure the quality, safety and efficacy of live attenuated yellow fever vaccines. In: WHO Expert Committee on Biological Standardization: seventy-first report. Geneva: World Health Organization; 2021 (WHO Technical Report Series, No. 1028, section 3.2.3, pp.20\u20131;). https:\/\/www.who.int\/publications\/i\/item\/9789240020146 ."},{"key":"10.1016\/j.vaccine.2022.04.095_b0030","unstructured":"Production and testing of the WHO yellow fever virus primary seed lot 213-77 and reference batch 168-73. In: WHO Expert Committee on Biological Standardization: Thirty-sixty report. Geneva: World Health Organization; 1985: Annex 6 (WHO Technical Report Series, No. 745.) https:\/\/www.who.int\/publications\/i\/item\/9241207450 ."},{"key":"10.1016\/j.vaccine.2022.04.095_b0035","doi-asserted-by":"crossref","unstructured":"Juan-Giner A, Kimathi D, Grantz KH, Hamaluba M, Kazooba P, Njuguna P, Fall G, Dia M, Bob NS, Monath TP, Barrett AD, Hombach J, Mulogo EM, Ampeire I, Karanja HK, Nyehangane D, Mwanga-Amumpaire J, Cummings DAT, Bejon P, Warimwe GM, Grais RF. Immunogenicity and safety of fractional doses of yellow fever vaccines: a randomised, double-blind, non-inferiority trial. Lancet. 2021 Jan 9;397(10269):119-127. doi: 10.1016\/S0140-6736(20)32520-4. PMID: 33422245.","DOI":"10.1016\/S0140-6736(20)32520-4"},{"issue":"4","key":"10.1016\/j.vaccine.2022.04.095_b0040","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0092-1157(87)80003-3","article-title":"The monkey safety test for neurovirulence of yellow fever vaccines: the utility of quantitative clinical evaluation and histological examination","volume":"15","author":"Levenbook","year":"1987","journal-title":"J Biol Stand."},{"issue":"1","key":"10.1016\/j.vaccine.2022.04.095_b0045","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0042-6822(03)00583-X","article-title":"Neurovirulence of yellow fever 17DD vaccine virus to rhesus monkeys","volume":"316","author":"Marchevsky","year":"2003","journal-title":"Virology"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22005485?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22005485?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:13:39Z","timestamp":1759403619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22005485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":9,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0264410X22005485"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.04.095","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"WHO working group meeting to amend WHO Recommendations to assure the quality, safety and efficacy of live attenuated yellow fever vaccines","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.04.095","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}